Literature DB >> 15277635

Prevalence of migraine on each day of the natural menstrual cycle.

E Anne MacGregor1, Allan Hackshaw.   

Abstract

Diary data from 155 women were analyzed using within-woman analysis. Compared with all other times of the cycle, migraine was 1.7 times more likely to occur during the 2 days before menstruation and 2.1 times more likely to be severe and 2.5 times more likely to occur during the first 3 days of menstruation and 3.4 times more likely to be severe. This confirms that migraine at menstruation is different from nonmenstrual attacks, even within individuals.

Entities:  

Mesh:

Year:  2004        PMID: 15277635     DOI: 10.1212/01.wnl.0000133134.68143.2e

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  53 in total

1.  Clinical trials report: sumatriptan-naproxen combination for symptomatic treatment of comorbid dysmenorrhea and migraine.

Authors:  E Anne MacGregor
Journal:  Curr Pain Headache Rep       Date:  2010-10

2.  Menstrual migraine: therapeutic approaches.

Authors:  E Anne Macgregor
Journal:  Ther Adv Neurol Disord       Date:  2009-09       Impact factor: 6.570

Review 3.  Transdermal hormonal therapy in perimenstrual migraine: why, when and how?

Authors:  Cristina Tassorelli; Rosaria Greco; Marta Allena; Erica Terreno; Rossella E Nappi
Journal:  Curr Pain Headache Rep       Date:  2012-10

Review 4.  Perimenstrual headache in adolescence.

Authors:  Andrew D Hershey
Journal:  Curr Pain Headache Rep       Date:  2012-10

Review 5.  Menstrual migraine.

Authors:  Ana Recober; Lynne O Geweke
Journal:  Curr Neurol Neurosci Rep       Date:  2005-03       Impact factor: 5.081

6.  Migraine in postmenopausal women and the risk of invasive breast cancer.

Authors:  Robert W Mathes; Kathleen E Malone; Janet R Daling; Scott Davis; Sylvia M Lucas; Peggy L Porter; Christopher I Li
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-11       Impact factor: 4.254

Review 7.  Estrogen, migraine, and vascular risk.

Authors:  Gianni Allais; Giulia Chiarle; Silvia Sinigaglia; Gisella Airola; Paola Schiapparelli; Chiara Benedetto
Journal:  Neurol Sci       Date:  2018-06       Impact factor: 3.307

Review 8.  Neurovascular pains: implications of migraine for the oral and maxillofacial surgeon.

Authors:  Donald R Nixdorf; Ana M Velly; Aurelio A Alonso
Journal:  Oral Maxillofac Surg Clin North Am       Date:  2008-05       Impact factor: 2.802

9.  Oestrogen increases nociception through ERK activation in the trigeminal ganglion: evidence for a peripheral mechanism of allodynia.

Authors:  C S Liverman; J W Brown; R Sandhir; R M Klein; K McCarson; N E J Berman
Journal:  Cephalalgia       Date:  2009-02-03       Impact factor: 6.292

10.  Oral zolmitriptan in the short-term prevention of menstrual migraine: a randomized, placebo-controlled study.

Authors:  Michael M Tuchman; Angela Hee; Ugochi Emeribe; Stephen Silberstein
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.